Literature DB >> 22962369

Ganfort, a blinding drug to the physician.

Lennard lee1, Chris Turnbull, Mohammed Majid Akhtar, James Fleet.   

Abstract

Ganfort eye drops are indicated for adult patients with open-angle glaucoma who have poor response to topical β-blockers or prostaglandin analogues. They contain 0.3 mg of bimatoprost (a prostaglandin) and 5 mg of timolol (β-blocker). The authors present a case of a 45-year-old man with glaucoma presenting with shortness of breath. On admission, he had a normal heart rate, pulse oximetry and examination. Despite being of low risk stratification using the Wells score and the Modified Geneva Score for pulmonary emboli, CT pulmonary angiogram scan subsequently showed extensive bilateral multiple large pulmonary emboli. This case demonstrates that the systemic absorption of ocular β blockers is extremely high and it bypasses the first pass metabolism. Therefore, even one drop of Ganfort into each eye once a day was sufficient to disguise the tachycardia of a large pulmonary emboli.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22962369      PMCID: PMC3448736          DOI: 10.1136/bcr.01.2012.5648

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  8 in total

1.  Systemic bioavailability and cardiopulmonary effects of 0.5% timolol eyedrops.

Authors:  Juha-Matti Korte; Timo Kaila; K Matti Saari
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2002-04-26       Impact factor: 3.117

2.  Syncope and falls due to timolol eye drops.

Authors:  Marije E Müller; Nathalie van der Velde; Jaap W M Krulder; Tischa J M van der Cammen
Journal:  BMJ       Date:  2006-04-22

3.  Severe bradycardia due to interaction of timolol eye drops and verapamil.

Authors:  S D Pringle; C J MacEwen
Journal:  Br Med J (Clin Res Ed)       Date:  1987-01-17

4.  Pharmacogenetic explanation for excessive beta-blockade following timolol eye drops. Potential for oral-ophthalmic drug interaction.

Authors:  T I Edeki; H He; A J Wood
Journal:  JAMA       Date:  1995 Nov 22-29       Impact factor: 56.272

5.  Accuracy of clinical assessment in the diagnosis of pulmonary embolism.

Authors:  M Miniati; R Prediletto; B Formichi; C Marini; G Di Ricco; L Tonelli; G Allescia; M Pistolesi
Journal:  Am J Respir Crit Care Med       Date:  1999-03       Impact factor: 21.405

6.  Timolol eyedrop-induced severe bronchospasm.

Authors:  S Ostergaard Laursen; P Bjerrum
Journal:  Acta Med Scand       Date:  1982

7.  Cardiovascular effects of ophthalmic timolol.

Authors:  C V Leier; N D Baker; P A Weber
Journal:  Ann Intern Med       Date:  1986-02       Impact factor: 25.391

8.  Guidelines on the diagnosis and management of acute pulmonary embolism: the Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC).

Authors:  Adam Torbicki; Arnaud Perrier; Stavros Konstantinides; Giancarlo Agnelli; Nazzareno Galiè; Piotr Pruszczyk; Frank Bengel; Adrian J B Brady; Daniel Ferreira; Uwe Janssens; Walter Klepetko; Eckhard Mayer; Martine Remy-Jardin; Jean-Pierre Bassand
Journal:  Eur Heart J       Date:  2008-08-30       Impact factor: 29.983

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.